| ATM kinase inhibition preferentially sensitizes p53-mutant glioma to ionizing radiation L Biddlestone-Thorpe, M Sajjad, E Rosenberg, JM Beckta, NCK Valerie, ... Clinical Cancer Research 19 (12), 3189-3200, 2013 | 210 | 2013 |
| Dynamic inhibition of ATM kinase provides a strategy for glioblastoma multiforme radiosensitization and growth control SE Golding, E Rosenberg, BR Adams, S Wignarajah, JM Beckta, ... Cell Cycle 11 (6), 1167-1173, 2012 | 113 | 2012 |
| Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin TP Kegelman, B Wu, SK Das, S Talukdar, JM Beckta, B Hu, L Emdad, ... Proceedings of the National Academy of Sciences 114 (2), 370-375, 2017 | 92 | 2017 |
| Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation J Sperlazza, M Rahmani, J Beckta, M Aust, E Hawkins, SZ Wang, ... Blood, The Journal of the American Society of Hematology 126 (12), 1462-1472, 2015 | 65 | 2015 |
| Orally bioavailable and blood–brain barrier-penetrating ATM inhibitor (AZ32) radiosensitizes intracranial gliomas in mice J Karlin, J Allen, SF Ahmad, G Hughes, V Sheridan, R Odedra, ... Molecular cancer therapeutics 17 (8), 1637-1647, 2018 | 55 | 2018 |
| Peptide library approach to uncover phosphomimetic inhibitors of the BRCA1 C-terminal domain ER White, L Sun, Z Ma, JM Beckta, BA Danzig, DE Hacker, M Huie, ... ACS chemical biology 10 (5), 1198-1208, 2015 | 43 | 2015 |
| Revisiting p53 for cancer-specific chemo-and radiotherapy: Ten years after JM Beckta, SF Ahmad, H Yang, K Valerie Cell cycle 13 (5), 710-713, 2014 | 39 | 2014 |
| Mutation of the BRCA1 SQ-cluster results in aberrant mitosis, reduced homologous recombination, and a compensatory increase in non-homologous end joining JM Beckta, SM Dever, N Gnawali, A Khalil, A Sule, SE Golding, ... Oncotarget 6 (29), 27674, 2015 | 28 | 2015 |
| Synthesis of water-soluble camptothecin–polyoxetane conjugates via click chemistry OY Zolotarskaya, AF Wagner, JM Beckta, K Valerie, KJ Wynne, H Yang Molecular pharmaceutics 9 (11), 3403-3408, 2012 | 28 | 2012 |
| Autophagy and radiosensitization in cancer K Sharma, R Goehe, JM Beckta, K Valerie, DA Gewirtz EXCLI journal 13, 178, 2014 | 27 | 2014 |
| Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity S Gayle, R Aiello, N Leelatian, JM Beckta, J Bechtold, P Bourassa, ... NAR cancer 3 (2), zcab021, 2021 | 18 | 2021 |
| Laser interstitial thermal therapy for treatment of cerebral radiation necrosis CS Hong, JM Beckta, AJ Kundishora, AA Elsamadicy, VL Chiang International Journal of Hyperthermia 37 (2), 68-76, 2020 | 15 | 2020 |
| Targeting DNA repair in gliomas JM Beckta, RS Bindra, AJ Chalmers Current Opinion in Neurology 32 (6), 878-885, 2019 | 13 | 2019 |
| Defining an intermediate-risk group for low-grade glioma: a national cancer database analysis V Jairam, BH Kann, HS Park, JA Miccio, JM Beckta, JB Yu, RS Prabhu, ... Anticancer Research 39 (6), 2911-2918, 2019 | 11 | 2019 |
| The use of low-dose radiation therapy in osteoarthritis: a review APH Dove, A Cmelak, K Darrow, KN McComas, M Chowdhary, J Beckta, ... International Journal of Radiation Oncology* Biology* Physics 114 (2), 203-220, 2022 | 10 | 2022 |
| Moderate hypofractionation and stereotactic body radiation therapy in the treatment of prostate cancer JM Beckta, JD Nosrati, BY James Urologic Oncology: Seminars and Original Investigations 37 (9), 619-627, 2019 | 10 | 2019 |
| MRI-guided laser interstitial thermal therapy for radiation necrosis in previously irradiated brain arteriovenous malformations CS Hong, BJ Cord, AJ Kundishora, AA Elsamadicy, JM Beckta, A Huttner, ... Practical Radiation Oncology 10 (4), e298-e303, 2020 | 8 | 2020 |
| DNA damage response in human stem cells and neural descendants JM Beckta, BR Adams, K Valerie ATM Kinase: Methods and Protocols, 375-390, 2017 | 7 | 2017 |
| Unsealed source: Scope of practice for radiopharmaceuticals among United States radiation oncologists U Shukla, IH Chowdhury, JM Beckta, JS Witt, M McFarlane, CJ Miller, ... Advances in Radiation Oncology 7 (5), 100827, 2022 | 6 | 2022 |
| Two-and three-dimensional live cell imaging of DNA damage response proteins JM Beckta, SC Henderson, K Valerie JoVE (Journal of Visualized Experiments), e4251, 2012 | 6 | 2012 |
